EpirubicinCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticBreast NeoplasmsFluorouracilDoxorubicinDrug Administration SchedulePaclitaxelVincristineChemotherapy, AdjuvantTaxoidsTreatment OutcomeAntineoplastic Agents, AlkylatingMethotrexateGranulocyte Colony-Stimulating FactorRazoxaneDisease-Free SurvivalCisplatinPhosphoramide MustardsPrednisoneNeoadjuvant TherapyEtoposideCombined Modality TherapySurvival AnalysisDose-Response Relationship, DrugAnthracyclinesSurvival RateInfusions, IntravenousVinblastineLeukopeniaNeutropeniaIfosfamideDeoxycytidineAlopeciaThiotepaRemission InductionNeoplasm StagingImmunosuppressive AgentsHematologic DiseasesAntineoplastic AgentsNeoplasm MetastasisPulse Therapy, DrugVomitingLymphoma, Non-HodgkinNauseaCarboplatinProlyl HydroxylasesMastectomy, RadicalFollow-Up StudiesMitoxantroneBusulfanTime FactorsLymphatic MetastasisReceptor, erbB-2PrednisoloneStomach NeoplasmsDrug Therapy, CombinationDrug EvaluationHematopoietic Stem Cell TransplantationMaximum Tolerated DoseInjections, IntravenousAdenocarcinomaAntibodies, Monoclonal, Murine-DerivedStomatitisProspective StudiesAmenorrheaPrognosisTamoxifenNaphthacenesHeart DiseasesVidarabineBone Marrow TransplantationDrug Resistance, Neoplasm